Literature DB >> 21082361

Mutations in the survival motor neuron (SMN) protein alter the dynamic nature of nuclear bodies.

Robert Morse1, Adrian G Todd, Debra J Shaw, Alison L McConville, Iain M Robinson, Philip J Young.   

Abstract

The childhood disorder spinal muscular atrophy (SMA) is caused by reduced expression of the survival motor neuron (SMN) protein. SMN is a multifunctional protein that has been implicated in the production, processing and transport of RNA and ribonucleoproteins (RNPs). Within the nucleus, SMN is predominantly targeted to Cajal bodies (CB), which are involved in the maturation and processing of several subclasses of RNPs. Here, we show that the SMN exon 2b-encoded domain (SMN2b) is independently sufficient to mediate CB targeting, but that the resulting bodies are less dynamic than those containing full-length SMN protein. We also show that while two SMN proteins harbouring SMA-causing point mutations (A2G and S262I) are efficiently targeted to CBs, they also display reduced nuclear movement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21082361     DOI: 10.1007/s12017-010-8139-1

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  60 in total

1.  Cell death and decreased synaptic protein expression in the ventral horn of Holstein-Friesian calves with spinal muscular atrophy.

Authors:  S Sisó; M Pumarola; I Ferrer
Journal:  J Comp Pathol       Date:  2003 Feb-Apr       Impact factor: 1.311

2.  Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis.

Authors:  Tessa L Carrel; Michelle L McWhorter; Eileen Workman; Honglai Zhang; Elizabeth C Wolstencroft; Christian Lorson; Gary J Bassell; Arthur H M Burghes; Christine E Beattie
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

3.  Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy.

Authors:  D Bühler; V Raker; R Lührmann; U Fischer
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

4.  SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.

Authors:  Thomas M Wishart; Jack P-W Huang; Lyndsay M Murray; Douglas J Lamont; Chantal A Mutsaers; Jenny Ross; Pascal Geldsetzer; Olaf Ansorge; Kevin Talbot; Simon H Parson; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2010-08-12       Impact factor: 6.150

5.  Consensus statement for standard of care in spinal muscular atrophy.

Authors:  Ching H Wang; Richard S Finkel; Enrico S Bertini; Mary Schroth; Anita Simonds; Brenda Wong; Annie Aloysius; Leslie Morrison; Marion Main; Thomas O Crawford; Anthony Trela
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

6.  SMN, the spinal muscular atrophy protein, forms a pre-import snRNP complex with snurportin1 and importin beta.

Authors:  Usha Narayanan; Jason K Ospina; Mark R Frey; Michael D Hebert; A Gregory Matera
Journal:  Hum Mol Genet       Date:  2002-07-15       Impact factor: 6.150

Review 7.  Chaperoning ribonucleoprotein biogenesis in health and disease.

Authors:  Livio Pellizzoni
Journal:  EMBO Rep       Date:  2007-04       Impact factor: 8.807

8.  The SMN protein is a key regulator of nuclear architecture in differentiating neuroblastoma cells.

Authors:  Allyson K Clelland; Nicholas P Kinnear; Lisa Oram; Julie Burza; Judith E Sleeman
Journal:  Traffic       Date:  2009-08-04       Impact factor: 6.215

9.  In vivo kinetics of Cajal body components.

Authors:  Miroslav Dundr; Michael D Hebert; Tatiana S Karpova; David Stanek; Hongzi Xu; Karl B Shpargel; U Thomas Meier; Karla M Neugebauer; A Gregory Matera; Tom Misteli
Journal:  J Cell Biol       Date:  2004-03-15       Impact factor: 10.539

10.  A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.

Authors:  Umrao R Monani; Matthew T Pastore; Tatiana O Gavrilina; Sibylle Jablonka; Thanh T Le; Catia Andreassi; Jennifer M DiCocco; Christian Lorson; Elliot J Androphy; Michael Sendtner; Michael Podell; Arthur H M Burghes
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.